Palomino Laboratories (PALX) Net Income towards Common Stockholders (2023 - 2025)

Palomino Laboratories has reported Net Income towards Common Stockholders for 3 years, with the latest figure at -$1.6 million in Q3 2025.

• Quarterly Net Income towards Common Stockholders fell 143536.85% year-over-year to -$1.6 million in Q3 2025, while the trailing twelve-month figure through Dec 2025 was -$1.7 million (down 565.15% YoY) and the FY2024 annual result came in at -$145866.0, down 22.73% from the prior year.
• Net Income towards Common Stockholders retreated to -$1.6 million in Q3 2025 per PALX's latest filing, from -$43775.0 in the prior quarter.
• Over five years, Net Income towards Common Stockholders peaked at -$1118.0 in Q3 2024 and troughed at -$1.6 million in Q3 2025.
• A 3-year average of -$226325.9 and a median of -$51304.0 in 2024 frame the typical range for Net Income towards Common Stockholders.
• The sharpest annual moves came in 2024 and 2025: Net Income towards Common Stockholders jumped 97.39% in 2024, then tumbled 143536.85% in 2025.
• Over 3 years, Net Income towards Common Stockholders stood at -$67487.0 in 2023, then slumped by 102.91% to -$136938.0 in 2024, then sank by 1072.69% to -$1.6 million in 2025.
• According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered -$1.6 million, -$43775.0, and -$25156.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.